UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (39) 39
life sciences & biomedicine (38) 38
humans (32) 32
male (22) 22
biological and medical sciences (18) 18
female (18) 18
medical sciences (17) 17
middle aged (16) 16
adult (14) 14
oncology (14) 14
aged (13) 13
antineoplastic combined chemotherapy protocols - therapeutic use (12) 12
animals (11) 11
treatment outcome (10) 10
hematology (9) 9
chemotherapy (8) 8
mice (8) 8
prognosis (8) 8
hematologic and hematopoietic diseases (7) 7
leukemias. malignant lymphomas. malignant reticulosis. myelofibrosis (7) 7
abridged index medicus (6) 6
biochemistry & molecular biology (6) 6
care and treatment (6) 6
combined modality therapy (6) 6
disease-free survival (6) 6
hematology, oncology and palliative medicine (6) 6
pharmacology. drug treatments (6) 6
adolescent (5) 5
analysis (5) 5
antineoplastic combined chemotherapy protocols - administration & dosage (5) 5
antineoplastic combined chemotherapy protocols - adverse effects (5) 5
cells, cultured (5) 5
lymphoma, non-hodgkin - drug therapy (5) 5
lymphomas (5) 5
aged, 80 and over (4) 4
antineoplastic agents (4) 4
antineoplastic agents - therapeutic use (4) 4
cancer (4) 4
cardiac & cardiovascular systems (4) 4
cardiology. vascular system (4) 4
cardiovascular system & cardiology (4) 4
clinical trials (4) 4
cyclophosphamide - administration & dosage (4) 4
doxorubicin - administration & dosage (4) 4
italy (4) 4
lymphoma (4) 4
lymphoma, non-hodgkin - therapy (4) 4
mediastinal neoplasms - therapy (4) 4
neoplasm staging (4) 4
patients (4) 4
prednisone - administration & dosage (4) 4
prospective studies (4) 4
tumors (4) 4
vincristine - administration & dosage (4) 4
allergy (3) 3
bleomycin - administration & dosage (3) 3
bone marrow transplantation (3) 3
carcinoma, non-small-cell lung - drug therapy (3) 3
cell biology (3) 3
cisplatin - administration & dosage (3) 3
cyclophosphamide (3) 3
cytarabine - administration & dosage (3) 3
cytarabine - therapeutic use (3) 3
doxorubicin (3) 3
drug administration schedule (3) 3
drug therapy (3) 3
genetics (3) 3
health aspects (3) 3
immunology (3) 3
leucovorin - administration & dosage (3) 3
lung neoplasms - drug therapy (3) 3
lung neoplasms - pathology (3) 3
lymphoma, non-hodgkin - radiotherapy (3) 3
mediastinal neoplasms - mortality (3) 3
mediastinal neoplasms - pathology (3) 3
medical research (3) 3
medicine & public health (3) 3
methotrexate (3) 3
methotrexate - administration & dosage (3) 3
methotrexate - therapeutic use (3) 3
micrornas - genetics (3) 3
micrornas - metabolism (3) 3
myocytes, cardiac - metabolism (3) 3
phosphorylation (3) 3
prednisone (3) 3
proportional hazards models (3) 3
retrospective studies (3) 3
steroids (3) 3
survival rate (3) 3
anesthesia. intensive care medicine. transfusions. cell therapy and gene therapy (2) 2
anthracyclines (2) 2
antimetabolites, antineoplastic - therapeutic use (2) 2
apoptosis (2) 2
b-cell lymphoma (2) 2
base sequence (2) 2
biology (2) 2
bleomycin (2) 2
bleomycin - therapeutic use (2) 2
bone marrow, stem cells transplantation. graft versus host reaction (2) 2
carcinoma, non-small-cell lung - pathology (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2009, Volume 374, Issue 9700, pp. 1512 - 1520
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hematologic and hematopoietic diseases | Antiviral agents | General aspects | Pharmacology. Drug treatments | Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis | Biological and medical sciences | Medical sciences | Antibiotics. Antiinfectious agents. Antiparasitic agents | Follow-Up Studies | Cytarabine - therapeutic use | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Cytarabine - adverse effects | Methotrexate - therapeutic use | Lymphoma, Non-Hodgkin - radiotherapy | Cranial Irradiation - methods | Central Nervous System Neoplasms - radiotherapy | Adult | Lymphoma, Non-Hodgkin - drug therapy | Drug Administration Schedule | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Combined Modality Therapy | Remission Induction | Methotrexate - adverse effects | Antimetabolites, Antineoplastic - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Antimetabolites, Antineoplastic - adverse effects | Aged | Lymphoma, Non-Hodgkin - mortality | Central Nervous System Neoplasms - drug therapy | Central Nervous System Neoplasms - mortality | Cytarabine | Patient outcomes | Central nervous system diseases | Dosage and administration | Lymphomas | Drug therapy, Combination | Methotrexate | Drug therapy | Data analysis | Disease | Monoclonal antibodies | Data collection | Radiation therapy | Patients | Lymphoma | Tropical diseases | Index Medicus | Abridged Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2013, Volume 14, Issue 10, pp. 981 - 988
Journal Article
The Lancet. Haematology, ISSN 2352-3026, 2016, Volume 4, Issue 1, pp. e15 - e23
Journal Article
Journal Article